ClinConnect ClinConnect Logo
Search / Trial NCT06215092

Perinatal and Psychological Correlates of Neurodevelopmental Disorders in Children.

Launched by BARTOSZ M. RADTKE · Jan 10, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hypoxia Dyslexia Mild Intellectual Disability Adhd Asd Learning Difficulties Social Emotional Functioning

ClinConnect Summary

This clinical trial is studying how certain factors during pregnancy and early life might affect children's development, particularly in relation to conditions like learning difficulties and neurodevelopmental disorders (which include issues like ADHD and autism). The researchers want to understand if there is a link between these early life factors and the risk of developing such disorders, as well as how children with these conditions think and feel compared to those without them. The study will include at least 500 children aged 5 to 18 who will be assessed by trained professionals using specific tasks and questions answered by parents and teachers.

To participate, children must be between 5 and 18 years old and fall into one of several groups: those with diagnosed neurodevelopmental disorders (like ADHD or autism), those facing learning challenges without a formal diagnosis, and a control group of children without any neurodevelopmental disorders. Participants can expect to undergo evaluations that focus on their cognitive skills (thinking abilities) and social-emotional skills (how they interact with others and manage their feelings). This study is currently recruiting participants, and it aims to provide valuable insights that could help improve support for children facing developmental challenges.

Gender

ALL

Eligibility criteria

  • Inclusion criteria for neurodevelopmental disorder groups:
  • age between 5 to 18 y.o.
  • diagnosed neurodevelopmental disorders, depending on the study group: 1) Developmental learning disorder; 2) Disorder of intellectual development, mild; 3) Attention deficit hyperactivity disorder; 4) Autism spectrum disorder
  • Inclusion criteria for learning difficulties:
  • age between 5 to 18 y.o.
  • difficulty in reading and/or writing without a diagnosis of Developmental learning disorder
  • Inclusion criteria for control group
  • age between 5 to 18 y.o.
  • without a diagnosis of any neurodevelopmental disorder
  • Exclusion criteria for learning difficulties
  • - diagnosis of Developmental learning disorder
  • Exclusion criteria for all groups:
  • age below 5 y.o. and equal to or above 19 y.o.
  • diagnosis of any neurodevelopmental disorders

About Bartosz M. Radtke

Bartosz M. Radtke is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through rigorous scientific inquiry. With a strong focus on innovative therapeutic approaches, the organization collaborates with leading research institutions and healthcare professionals to design and implement clinical trials that adhere to the highest ethical and regulatory standards. Leveraging extensive expertise in trial management and a deep understanding of patient needs, Bartosz M. Radtke aims to facilitate the development of safe and effective treatments across various therapeutic areas, ultimately contributing to the enhancement of healthcare practices and patient quality of life.

Locations

Gdansk, Pomerania, Poland

Patients applied

0 patients applied

Trial Officials

Urszula Sajewicz-Radtke, Ph.D.

Principal Investigator

Laboratory of Psychological and Educational Tests

Bartosz M Radtke, Ph.D.

Study Director

Laboratory of Psychological and Educational Tests

Ariadna Łada-Maśko, Ph.D.

Principal Investigator

Laboratory of Psychological and Educational Tests

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported